Identification of prostate cancer cells from voided urine in a microfluidic device was explored, integrating prostate-specific membrane antigen (PSMA)-based immunocapture with hexaminolevulinate (HAL)-based photodetection, for providing an accurate noninvasive alternative to current diagnostic methods. The gene discussed is FOLH1; the disease is prostate cancer.